INJ’s $70 Scenario Depends on Chart Breakouts, Not Injective’s Washington Meetings
Injective says it met with US officials and points to regulated-market milestones, but neither guarantees demand for INJ. A $70 scenario depends on holding key support and breaking through several chart resistance levels—a roughly 9.2-fold climb from the cited price.
Read Full Article